Lyle Gurrin

Lyle C. Gurrin is a Professor of Biostatistics in the Melbourne School of Population and Global Health at the University of Melbourne, within the Faculty of Medicine, Dentistry and Health Sciences. He holds a BSc (Hons), PhD from the University of Western Australia, a Graduate Certificate in University Teaching, Accredited Statistician (AStat) status, and is a Fellow of the Royal Statistical Society (FRSS). Gurrin joined the University of Melbourne in 2003 as a Senior Lecturer and was promoted to Professor in 2018, recognizing his international leadership in developing statistical methodologies for causal inference with public health applications. He leads the biostatistical components of major epidemiological programs on the genetic causes of haemochromatosis and the prevention of allergies, including the HealthNuts study. His research encompasses methods for longitudinal and correlated data analysis, mediation analysis in observational studies, trustworthiness of randomized controlled trials, individual participant data meta-analysis, and applications to food allergy, peanut allergy prevention, asthma, lung function, occupational exposures, air pollution, hereditary haemochromatosis, iron overload, smoking inequalities, and disability in cohort studies. Gurrin teaches biostatistics to postgraduate students in epidemiology, public health, medicine, and mathematics, contributing to the Master of Biostatistics program offered both on-campus and online through the Biostatistics Collaboration of Australia. He serves as President of the Victorian Branch of the Statistical Society of Australia and collaborates widely across disciplines.

Gurrin's scholarly impact is substantial, with over 19,700 citations across 383 publications. Key works include 'Association Between Earlier Introduction of Peanut and Prevalence of Peanut Allergy in Infants in Australia' (2022), 'Benefits and Harms of Breast Cancer Screening: Cohort Study of Breast Cancer Mortality and Overdiagnosis' (2023), 'Checklist to Assess Trustworthiness in Randomised Controlled Trials (TRACT Checklist): Concept Proposal and Pilot' (2023), 'Peanut Allergen Threshold Study (PATS): Validation of Eliciting Dose' (2013), and 'Cohort Profile: The HealthNuts Study: Population Prevalence and Trajectories of Food Allergies' (2015). His contributions advance data integrity assessments in clinical research and methodological innovations in epidemiology, enhancing scientific rigour in public health studies. Gurrin has secured funding from the National Health and Medical Research Council, including a Career Development Fellowship.

Professional Email: lgurrin@unimelb.edu.au